Literature DB >> 30104048

Prevention of Ebola virus disease through vaccination: where we are in 2018.

Yves Lévy1, Clifford Lane2, Peter Piot3, Abdul Habib Beavogui4, Mark Kieh5, Bailah Leigh6, Seydou Doumbia7, Eric D'Ortenzio8, Claire Lévy-Marchal8, Jerome Pierson2, Deborah Watson-Jones3, Vinh-Kim Nguyen9, Heidi Larson3, Julia Lysander5, Christine Lacabaratz8, Rodolphe Thiebaut8, Augustin Augier10, David Ishola3, Stephen Kennedy5, Geneviève Chêne8, Brian Greenwood3, James Neaton11, Yazdan Yazdanpanah8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30104048      PMCID： PMC6128979          DOI： 10.1016/S0140-6736(18)31710-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial.

Authors:  May S ElSherif; Catherine Brown; Donna MacKinnon-Cameron; Li Li; Trina Racine; Judie Alimonti; Thomas L Rudge; Carol Sabourin; Peter Silvera; Jay W Hooper; Steven A Kwilas; Nicole Kilgore; Christopher Badorrek; W Jay Ramsey; D Gray Heppner; Tracy Kemp; Thomas P Monath; Teresa Nowak; Shelly A McNeil; Joanne M Langley; Scott A Halperin
Journal:  CMAJ       Date:  2017-06-19       Impact factor: 8.262

2.  Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

Authors:  Lihua Wu; Zhe Zhang; Hainv Gao; Yuhua Li; Lihua Hou; Hangping Yao; Shipo Wu; Jian Liu; Ling Wang; You Zhai; Huilin Ou; Meihua Lin; Xiaoxin Wu; Jingjing Liu; Guanjing Lang; Qian Xin; Guolan Wu; Li Luo; Pei Liu; Jianzhong Shentu; Nanping Wu; Jifang Sheng; Yunqing Qiu; Wei Chen; Lanjuan Li
Journal:  Hum Vaccin Immunother       Date:  2017-07-14       Impact factor: 3.452

3.  Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year.

Authors:  Rebecca L Winslow; Iain D Milligan; Merryn Voysey; Kerstin Luhn; Georgi Shukarev; Macaya Douoguih; Matthew D Snape
Journal:  JAMA       Date:  2017-03-14       Impact factor: 56.272

4.  Chimpanzee Adenovirus Vector Ebola Vaccine.

Authors:  Julie E Ledgerwood; Adam D DeZure; Daphne A Stanley; Emily E Coates; Laura Novik; Mary E Enama; Nina M Berkowitz; Zonghui Hu; Gyan Joshi; Aurélie Ploquin; Sandra Sitar; Ingelise J Gordon; Sarah A Plummer; LaSonji A Holman; Cynthia S Hendel; Galina Yamshchikov; Francois Roman; Alfredo Nicosia; Stefano Colloca; Riccardo Cortese; Robert T Bailer; Richard M Schwartz; Mario Roederer; John R Mascola; Richard A Koup; Nancy J Sullivan; Barney S Graham
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

5.  Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.

Authors:  Iain D Milligan; Malick M Gibani; Richard Sewell; Elizabeth A Clutterbuck; Danielle Campbell; Emma Plested; Elizabeth Nuthall; Merryn Voysey; Laura Silva-Reyes; M Juliana McElrath; Stephen C De Rosa; Nicole Frahm; Kristen W Cohen; Georgi Shukarev; Nicola Orzabal; Wilbert van Duijnhoven; Carla Truyers; Nora Bachmayer; Daniel Splinter; Nathaly Samy; Maria Grazia Pau; Hanneke Schuitemaker; Kerstin Luhn; Benoit Callendret; Johan Van Hoof; Macaya Douoguih; Katie Ewer; Brian Angus; Andrew J Pollard; Matthew D Snape
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

6.  EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.

Authors:  Andrea Marzi; Shelly J Robertson; Elaine Haddock; Friederike Feldmann; Patrick W Hanley; Dana P Scott; James E Strong; Gary Kobinger; Sonja M Best; Heinz Feldmann
Journal:  Science       Date:  2015-08-06       Impact factor: 47.728

7.  Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.

Authors:  Stephen B Kennedy; Fatorma Bolay; Mark Kieh; Greg Grandits; Moses Badio; Ripley Ballou; Risa Eckes; Mark Feinberg; Dean Follmann; Birgit Grund; Swati Gupta; Lisa Hensley; Elizabeth Higgs; Krisztina Janosko; Melvin Johnson; Francis Kateh; James Logue; Jonathan Marchand; Thomas Monath; Martha Nason; Tolbert Nyenswah; François Roman; Eric Stavale; Julian Wolfson; James D Neaton; H Clifford Lane
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

8.  A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

Authors:  Katie Ewer; Tommy Rampling; Navin Venkatraman; Georgina Bowyer; Danny Wright; Teresa Lambe; Egeruan B Imoukhuede; Ruth Payne; Sarah Katharina Fehling; Thomas Strecker; Nadine Biedenkopf; Verena Krähling; Claire M Tully; Nick J Edwards; Emma M Bentley; Dhanraj Samuel; Geneviève Labbé; Jing Jin; Malick Gibani; Alice Minhinnick; Morven Wilkie; Ian Poulton; Natalie Lella; Rachel Roberts; Felicity Hartnell; Carly Bliss; Kailan Sierra-Davidson; Jonathan Powlson; Eleanor Berrie; Richard Tedder; Francois Roman; Iris De Ryck; Alfredo Nicosia; Nancy J Sullivan; Daphne A Stanley; Olivier T Mbaya; Julie E Ledgerwood; Richard M Schwartz; Loredana Siani; Stefano Colloca; Antonella Folgori; Stefania Di Marco; Riccardo Cortese; Edward Wright; Stephan Becker; Barney S Graham; Richard A Koup; Myron M Levine; Ariane Volkmann; Paul Chaplin; Andrew J Pollard; Simon J Draper; W Ripley Ballou; Alison Lawrie; Sarah C Gilbert; Adrian V S Hill
Journal:  N Engl J Med       Date:  2015-01-28       Impact factor: 91.245

9.  Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.

Authors:  Milagritos D Tapia; Samba O Sow; Kirsten E Lyke; Fadima Cheick Haidara; Fatoumata Diallo; Moussa Doumbia; Awa Traore; Flanon Coulibaly; Mamoudou Kodio; Uma Onwuchekwa; Marcelo B Sztein; Rezwanul Wahid; James D Campbell; Marie-Paule Kieny; Vasee Moorthy; Egeruan B Imoukhuede; Tommy Rampling; Francois Roman; Iris De Ryck; Abbie R Bellamy; Len Dally; Olivier Tshiani Mbaya; Aurélie Ploquin; Yan Zhou; Daphne A Stanley; Robert Bailer; Richard A Koup; Mario Roederer; Julie Ledgerwood; Adrian V S Hill; W Ripley Ballou; Nancy Sullivan; Barney Graham; Myron M Levine
Journal:  Lancet Infect Dis       Date:  2015-11-04       Impact factor: 25.071

10.  Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV.

Authors:  Anne Rechtien; Laura Richert; Hadrien Lorenzo; Gloria Martrus; Boris Hejblum; Christine Dahlke; Rahel Kasonta; Madeleine Zinser; Hans Stubbe; Urte Matschl; Ansgar Lohse; Verena Krähling; Markus Eickmann; Stephan Becker; Rodolphe Thiébaut; Marcus Altfeld; Marylyn M Addo
Journal:  Cell Rep       Date:  2017-08-29       Impact factor: 9.423
View more
  20 in total

Review 1.  Ebola Virus in the Democratic Republic of the Congo: Advances and Remaining Obstacles in Epidemic Control, Clinical Care, and Biomedical Research.

Authors:  Julie Erb-Alvarez; Aaron M Wendelboe; Daniel S Chertow
Journal:  Chest       Date:  2019-09-10       Impact factor: 9.410

2.  Hantavirus entry: Perspectives and recent advances.

Authors:  Eva Mittler; Maria Eugenia Dieterle; Lara M Kleinfelter; Megan M Slough; Kartik Chandran; Rohit K Jangra
Journal:  Adv Virus Res       Date:  2019-08-07       Impact factor: 9.937

3.  Risk factors for Ebola virus disease among household care providers, Sierra Leone, 2015.

Authors:  Nadezhda Duffy; Dana Bruden; Harold Thomas; Erin Nichols; Barbara Knust; Thomas Hennessy; Mary R Reichler
Journal:  Int J Epidemiol       Date:  2022-10-13       Impact factor: 9.685

4.  Single-component multilayered self-assembling nanoparticles presenting rationally designed glycoprotein trimers as Ebola virus vaccines.

Authors:  Linling He; Anshul Chaudhary; Xiaohe Lin; Cindy Sou; Tanwee Alkutkar; Sonu Kumar; Timothy Ngo; Ezra Kosviner; Gabriel Ozorowski; Robyn L Stanfield; Andrew B Ward; Ian A Wilson; Jiang Zhu
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

5.  Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.

Authors:  Yap Boum; Aitana Juan-Giner; Matt Hitchings; Aboubacar Soumah; Thomas Strecker; Mariama Sadjo; Hannah Cuthbertson; Peter Hayes; Marie Tchaton; Jean-Paul Jemmy; Carolyn Clarck; Deborah King; Elisabetta Maria Faga; Stephan Becker; Bassam Halis; Norheim Gunnstein; Miles Carroll; John-Arne Røttingen; Mandy Kader Kondé; Moise Doumbia; Ana-Maria Henao-Restrepo; Marie-Paule Kieny; Mohamed Cisse; Bertrand Draguez; Rebecca F Grais
Journal:  Vaccine       Date:  2020-06-01       Impact factor: 3.641

Review 6.  Persistence and Sexual Transmission of Filoviruses.

Authors:  Brayden G Schindell; Andrew L Webb; Jason Kindrachuk
Journal:  Viruses       Date:  2018-12-02       Impact factor: 5.048

7.  Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin.

Authors:  Evelyn M Covés-Datson; Julie Dyall; Lisa Evans DeWald; Steven R King; Derek Dube; Maureen Legendre; Elizabeth Nelson; Kelly C Drews; Robin Gross; Dawn M Gerhardt; Lisa Torzewski; Elena Postnikova; Janie Y Liang; Bhupal Ban; Jagathpala Shetty; Lisa E Hensley; Peter B Jahrling; Gene G Olinger; Judith M White; David M Markovitz
Journal:  PLoS Negl Trop Dis       Date:  2019-07-29

8.  Effects of vaccines in protecting against Ebola virus disease: protocol for a systematic review.

Authors:  Lindi Mathebula; Duduzile Edith Ndwandwe; Elizabeth Pienaar; Charles Shey Wiysonge
Journal:  BMJ Open       Date:  2019-07-03       Impact factor: 2.692

9.  Generation and Characterization of a Mouse-Adapted Makona Variant of Ebola Virus.

Authors:  Mable Chan; Anders Leung; Bryan D Griffin; Robert Vendramelli; Nikesh Tailor; Kevin Tierney; Jonathan Audet; Darwyn Kobasa
Journal:  Viruses       Date:  2019-10-26       Impact factor: 5.048

10.  Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease.

Authors:  Nancy A Niemuth; Dawn Fallacara; Cheryl A Triplett; Sanjay M Tamrakar; Alisha Rajbhandari; Clint Florence; Lucy Ward; Anthony Griffiths; Ricardo Carrion; Yenny Goez-Gazi; Kendra J Alfson; Hilary M Staples; Trevor Brasel; Jason E Comer; Shane Massey; Jeanon Smith; Andrew Kocsis; Jake Lowry; Sara C Johnston; Aysegul Nalca; Arthur J Goff; Amy C Shurtleff; Margaret L Pitt; John Trefry; Michael P Fay
Journal:  PLoS One       Date:  2021-07-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.